| 
| Firm | Analyst | Phone | E-Mail | | Biotech Stock Research | David Miller | 206-528-8110 | david.miller@biotechstockresearch.com | | Brean Murray, Carret & Co. | Ling Wang, CFA | 212-702-6680 | ling.wang@bmur.com | | Cantor Fitzgerald | Pamela Bassett, DMD | 212-829-4769 | pbassett@cantor.com | | Lazard Capital Markets | Joel Sendek | 212-632-1926 | joel.sendek@lazardcap.com | | Morgan Joseph and Co. | Shiv Kapoor | 415-287-4190 | skapoor@morganjoseph.com | | Oppenheimer Co. Inc. | Bret Holley, Ph.D. | 212-667-7289 | bret.holley@opco.com | | RBC Capital Markets | Jason Kantor, Ph.D. | 415-633-8565 | jason.kantor@rbccm.com |
|
| ImmunoGen is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding ImmunoGen's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ImmunoGen or its management. ImmunoGen does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
|